IDEAYA Biosciences, Inc. (IDYA)

Name: IDEAYA Biosciences, Inc. (IDYA) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0001676725 · Nasdaq · Pharmaceutical Preparations

Sector Manufacturing
Incorporated DE
Fiscal year ends Dec 31

For the year ended 2025-12-31, IDEAYA Biosciences, Inc. reported revenue of $218.71M.

Key ratios (year ended 2025-12-31)

-72.8%

Operating margin

-52.0%

Net margin

-11.1%

Return on year-end equity

n/m

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-08

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31
Revenue	n/a	$218.71M	$7.00M	$23.39M	$50.93M	$27.94M	$19.54M	$0	n/a	n/a
R&D Expense	$374.01M	$314.70M	$294.67M	$129.51M	$89.54M	$58.16M	$39.70M	$34.32M	$31.75M	$12.38M
Operating Income	-$216.95M	-$159.31M	-$326.98M	-$134.43M	-$62.50M	-$50.27M	-$35.34M	-$44.27M	-$36.42M	-$14.44M
Depreciation & Amortization	$2.76M	$2.70M	$2.39M	$2.48M	$2.10M	$1.73M	$1.38M	$1.25M	$886.0K	$391.0K
EBITDA	-$214.19M	-$156.61M	-$324.59M	-$131.95M	-$60.40M	-$48.54M	-$33.96M	-$43.03M	-$35.53M	-$14.05M
Net Income	-$175.02M	-$113.70M	-$274.48M	-$112.96M	-$58.66M	-$49.76M	-$34.49M	-$41.98M	-$34.35M	-$11.86M
EPS (Diluted)	n/a	-$1.28	-$3.36	-$1.96	-$1.42	-$1.41	-$1.40	n/a	n/a	n/a
Total Assets	$1.31B	$1.11B	$1.12B	$649.32M	$387.97M	$381.35M	$298.27M	$113.00M	$96.54M	n/a
Total Liabilities	$110.79M	$86.39M	$64.94M	$28.23M	$38.51M	$79.83M	$100.00M	$12.60M	$7.10M	n/a
Shareholders' Equity	$1.20B	$1.02B	$1.06B	$621.09M	$349.45M	$301.51M	$198.27M	$100.40M	-$48.95M	-$15.74M
Cash & Equivalents	$272.59M	$112.83M	$84.38M	$157.02M	$68.63M	$92.05M	$72.04M	$34.07M	$20.50M	$5.96M
Operating Cash Flow	-$111.66M	-$71.10M	-$247.58M	-$115.22M	-$87.17M	-$55.78M	$55.46M	-$39.31M	-$27.62M	-$12.22M
Capital Expenditures	$2.21M	$2.37M	$3.86M	$2.37M	$3.44M	$2.64M	$493.0K	$1.35M	$1.71M	$1.76M
Free Cash Flow	-$113.87M	-$73.47M	-$251.44M	-$117.59M	-$90.62M	-$58.42M	$54.97M	-$40.67M	-$29.33M	-$13.98M
Shares Outstanding	96.38M	87.80M	86.50M	65.04M	48.19M	38.53M	29.54M	20.34M	1.34M	n/a
Weighted Average Diluted Shares	n/a	88.49M	81.68M	57.52M	41.44M	35.25M	24.72M	n/a	n/a	n/a
EPS (Basic)	n/a	-$1.28	-$3.36	-$1.96	-$1.42	-$1.41	-$1.40	n/a	n/a	n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView